Australia's largest stock trading and investment forum Australia's #1 stock forum

From what I've seen is that each generation is better than the...

First 140 Last

Share
Profile

Follow
trent3727

6,678 Posts.

224

18/01/25

13:45

Post #: 77459839
Share

Originally posted by Bunn-Wackett: ↑

So we've got a global reputation of being stupid? Any danger of a line or two to tell me why you think that?

... and a cowardly pawn to the major nations? You're going to roll out Afghanistan and Vietnam aren't you?

I reckon we've done alright in a few hundred years and I'm sure there'd be worse places to live. From what I've seen is that each generation is better than the one previous and they have their own challenges, the current challenge is to what degree ($'s, legal, effort) we identify and respond to what seems to be a never ending list of issues that affects minorities, where's the cut off point?

You could ask 'what challenges did Boomers have?'... well it's an argument I'll not win and I don't want to pit one generation against another and despite sticking up for Boomers against one eyed "Whoa is me, it's all Boomers fault", I reckon the current generation is so much better than mine in so many ways.

Expand

From what I've seen is that each generation is better than the one previous"

OK so we are so much better off.. how?
Upvote

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 140 Last

SPONSORED BY